Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects

Behavioural Brain Research

Volumn 246, Issue , 2013, Pages 103-110

  de Andrade Strauss, Christiana Villela ^a   Vicente, Maria Adrielle ^a   Zangrossi, Helio ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anxiety; Panic; Serotonin and amygdala

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; MIDAZOLAM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPANIC ACTIVITY; ARTICLE; BASOLATERAL AMYGDALA; CONFLICT; CONTROLLED STUDY; DRINKING; LIGHT DARK CYCLE; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PUNISHMENT; RAT; TRANQUILIZING ACTIVITY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DARK ADAPTATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCAPE REACTION; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MICROINJECTIONS; MIDAZOLAM; PANIC DISORDER; PIPERAZINES; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; WATER DEPRIVATION;

EID: 84876328449     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.03.005     Document Type: Article

References (47)

1. Davis M. The role of the amygdala in fear and anxiety. Annual Review of Neuroscience 1992, 15:353-375. [review].
2. Fanselow M.S., Gale G.D. The amygdala, fear, and memory. Annals of the New York Academy of Sciences 2003, 985:125-134. [review].
3. Hodges H., Green S., Glenn B. Evidence that the amygdala is involved in benzodiazepines and serotonergic effects on punished responding but not discrimination. Psychopharmacology 1987, 929:491-504.
4. Deakin J.F.W., Graeff F.G. 5-HT and mechanisms of defense. Journal of Psychopharmacology 1991, 5:305-315.
5. Lowry C.A., Johnson P.L., Hay-Schmidt A., Mikkelsen J., Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress 2005, 8:233-246.
6. Millan M.J. Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie 2005, 60:441-460.
7. Savitz J., Lucki I., Drevets W.C. 5-HT(1A) receptor function in major depressive disorder. Progress in Neurobiology 2009, 88:17-31.
8. Cunningham L.A. Depression & anxiety in the primary care setting. Comprehensive Therapy 1997, 23:400-406. [review].
9. Cloos J.M. The treatment of panic disorder. Current Opinion in Psychiatry 2005, 1:45-50.
10. Ganasen K.A., Stein D.J. Pharmacotherapy of social anxiety disorder. Current Topics in Behavioral Neurosciences 2010, 2:487-503.
11. Campbell B.M., Merchant K.M. Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment. Brain Research 2003, 993(1-2):1-9.
12. de Mello Cruz A.P., Pinheiro G., Alves S.H., Ferreira G., Mendes M., Faria L., et al. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. Psychopharmacology 2005, 182:345-354.
13. Christianson J.P., Ragole T., Amat J., Greenwood B.N., Strong P.V., Paul E.D., et al. 5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress. Biological Psychiatry 2010, 67:339-345.
14. Overstreet D.H., Knapp D.J., Angel R.A., Navarro M., Breese G.R. Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands. Psychopharmacology 2006, 187:1-12.
15. Vicente M.A., Zangrossi H. Serotonin-2C receptors in the basolateral nucleus of the amygdala mediate the anxiogenic effect of acute imipramine and fluoxetine administration. International Journal of Neuropsychopharmacology 2011, 14:1-12. [erratum in: Int J Neuropsychopharmacol 2012; 15:401].
16. Zangrossi H., Graeff F.G. Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Research Bulletin 1997, 1:1-5.
17. Graeff F.G., Zangrossi H. Animal models of anxiety disorders. Textbook of biological psychiatry 2002, 879-893. Wiley and Sons, London. H. D'Haenen, J.A. den Boer, H. Westenberg, P. Willner (Eds.).
18. Pinheiro S.H., Zangrossi H., Del-Ben C.M., Graeff F.G. Elevated mazes as animal models of anxiety: effects of serotonergic agents. Anais da Academia Brasileira de Ciencias 2007, 79:71-85.
19. Blanchard D.C., Griebel G., Blanchard R.J. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neuroscience and Biobehavioral Reviews 2001, 25:205-218.
20. McNaughton N., Corr P.J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neuroscience and Biobehavioral Reviews 2004, 28:285-305.
21. Mobbs D., Petrovic P., Marchant J.L., Hassabis D., Weiskopf N., Seymour B., et al. When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science 2007, 317:1079-1083.
22. McNaughton N., Zangrossi H. Animal models of anxiety, fear and defense: theoretical to the modeling of anxiety in animals. Handbook of Anxiety and Fear 2008, vol. 17:11-27. Elsevier, Amsterdam.
23. Zangrossi H., Graeff F.G. Behavioral effects of intra-amygdala injections of GABA and 5-HT acting drugs in the elevated plus-maze. Brazilian Journal of Medical and Biological Research 1994, 27:2453-2456.
24. Gonzalez L.E., Andrews N., File S.E. 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Research 1996, 732:145-153.
25. Zangrossi H., Viana M.B., Graeff F.G. Anxiolytic effect of intra-amygdala injection of midazolam and 8-hydroxy-2-(di-n-propylamino)tetralin in the elevated T-maze. European Journal of Pharmacology 1999, 369:267-270.
26. Leite-Panissi C.R., Ferrarese A.A., Terzian A.L., Menescal-de-Oliveira L. Serotoninergic activation of the basolateral amygdala and modulation of tonic immobility in guinea pig. Brain Research Bulletin 2006, 69:356-364.
27. Engin E., Treit D. The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:1399-1419.
28. Graeff F.G., Viana M.B., Tomaz C. The elevated T maze, a new experimental model of anxiety and memory: effect of diazepam. Brazilian Journal of Medical and Biological Research 1993, 26:67-70.
29. Viana M.B., Tomaz C., Graeff F.G. The elevated T-maze: a new animal model of anxiety and memory. Pharmacology Biochemistry and Behavior 1994, 3:549-554.
30. Teixeira R.C., Zangrossi H., Graeff F.G. Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety. Pharmacology Biochemistry and Behavior 2000, 65:571-576.
31. Poltronieri S.C., Zangrossi H., de Barros Viana M. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behavioural Brain Research 2003, 147:185-192.
32. Pinheiro S.N., Del-Ben C.M., Zangrossi H., Graeff F.G. Anxiolytic and panicolytic effects of escitalopram in the elevated T-maze. Journal of Psychopharmacology 2008, 22:132-137.
33. Millan M.J., Brocco M. The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines. European Journal of Pharmacology 2003, 463:67-96.
34. Pelosi G.G., Resstel L.L., Soares V.P., Zangrossi H., Guimarães F.S., Corrêa F.M. Anxiolytic-like effect of noradrenaline microinjection into the dorsal periaqueductal gray of rats. Behavioural Pharmacology 2009, 20:252-259.
35. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, San Diego, Academic Press. 6th ed.
36. Zanoveli J.M., Nogueira R.L., Zangrossi H. Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze. European Journal of Pharmacology 2003, 473:153-161.
37. Bueno C.H., Zangrossi H., Viana M.B. The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests. Brazilian Journal of Medical and Biological Research 2005, 38:1697-1701.
38. Green S., Vale A.L. Role of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats. Behavioural Pharmacology 1992, 3:261-264.
39. Pesold C., Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Research 1995, 671(2 (February)):213-221.
40. Moreira C.M., Masson S., Carvalho M.C., Brandão M.L. Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei. Brain Research Bulletin 2007, 71:466-474.
41. Carvalho M.C., Moreira C.M., Zanoveli J.M., Brandão M.L. Central, but not basolateral, amygdala involvement in the anxiolytic-like effects of midazolam in rats in the elevated plus maze. Journal of Psychopharmacology 2012, 26:543-554.
42. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiological Reviews 2003, 83:803-834.
43. Kemble E.D., Blanchard D.C., Blanchard R.J. Effects of regional amygdaloid lesions on flight and defensive behaviors of wild black rats (Rattus rattus). Physiology and Behavior 1990, 48:1-5.
44. Greenwood B.N., Strong P.V., Fleshner M. Lesions of the basolateral amygdala reverse the long-lasting interference with shuttle box escape produced by uncontrollable stress. Behavioural Brain Research 2010, 211:71-76.
45. Zanoveli J.M., Pobbe R.L., de Bortoli V.C., Carvalho M.C., Brandão M.L., Zangrossi H. Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine. International Journal of Neuropsychopharmacology 2010, 13:1079-1088.
46. Schenberg L.C., Bittencourt A.S., Sudré E.C., Vargas L.C. Modeling panic attacks. Neuroscience and Biobehavioral Reviews 2001, 7-8:647-659.
47. Graeff F.G. Serotonin, the periaqueductal gray and panic. Neuroscience and Biobehavioral Reviews 2004, 3:239-259. [review].